orphanet journal of rare diseases | Journament

Journal Ranking

#2092 / 33,951
📉 Poor
Overall Score
39.3/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
34
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 1 day ago

orphanet journal of rare diseases

Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
scopus ncbi ulakbim sci
Short Name orphanet j rare dis
Abbreviated Name orphanet j rare dis
ISSN 1750-1172
Aim and Scope
URL https://link.springer.com/journal/13023/volumes-and-issues
Author Instructions

Publications Per Year

Recent Articles (23 total)

2019
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
Vanhoorne, V;Peeters, E;Van Tongelen, I;Boussery, K;Wynendaele, E;De Spiegeleer, B;Remon, J P;Vervaet, C;
Vol. 14 , No. 1 , pp. 186
471 views DOI Abstract
2020
The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease.
Bevilacqua, Jorge A;Guecaimburu Ehuletche, Maria Del Rosario;Perna, Abayuba;Dubrovsky, Alberto;Franca, Marcondes C;Vargas, Steven;Hegde, Madhuri;Claeys, Kristl G;Straub, Volker;Daba, Nadia;Faria, Roberta;Periquet, Magali;Sparks, Susan;Thibault, Nathan;Araujo, Roberto;
Vol. 15 , No. 1 , pp. 11
449 views DOI Abstract
2018
Compounded medication for patients with rare diseases
Dooms, Marc;Carvalho, Maria;
Vol. 13 , No. 1 , pp. 1-8
447 views Abstract
2019
Incontinentia pigmenti burden scale: designing a family burden questionnaire.
Taieb, Charles;Hadj-Rabia, Smail;Monnet, Jacques;Bennani, Mohammed;Bodemer, Christine;, ;
Vol. 14 , No. 1 , pp. 271
444 views DOI Abstract
2019
"Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease.
Ambrosini, Anna;Quinlivan, Ros;Sansone, Valeria A;Meijer, Ingeborg;Schrijvers, Guus;Tibben, Aad;Padberg, George;de Wit, Maarten;Sterrenburg, Ellen;Mejat, Alexandre;Breukel, Alexandra;Rataj, Michal;Lochmüller, Hanns;Willmann, Raffaella;, ;
Vol. 14 , No. 1 , pp. 126
416 views DOI Abstract
2019
A cost of illness study evaluating the burden of Wolfram syndrome in the United Kingdom.
Eljamel, Sana;Ghosh, Wrik;De Stone, Sachin;Griffiths, Annabel;Barrett, Timothy;Thompson, Richard;
Vol. 14 , No. 1 , pp. 185
392 views DOI Abstract
2012
Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases
Caron, Molster;Leanne, Youngs;Emma, Hammond;Hugh, Dawkins;
Vol. 7 , No. 1 , pp. 50-
387 views Abstract
2019
Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis.
Connolly, Mark P;Panda, Saswat;Patris, Julien;Hazenberg, Bouke P C;
Vol. 14 , No. 1 , pp. 220
358 views DOI Abstract
2018
The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
Odnoletkova, Irina;Kindle, Gerhard;Quinti, Isabella;Grimbacher, Bodo;Knerr, Viviane;Gathmann, Benjamin;Ehl, Stephan;Mahlaoui, Nizar;Wilder, Philippe Van;Bogaerts, Kris;Vries, Esther de;Taskforce, in collaboration with the Plasma Protein Therapeutics Association (PPTA);
Vol. 13 , No. 1 , pp. 1-17
349 views Abstract
2019
Under-utilisation of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research
Solebo, A.
Vol. 14 , pp. 0-0
347 views DOI
View All 23 Articles
39
Overall
Poor
31
35
30
40
34
50
0
0
0
0
0
Journament

Overall Quality Score

39.3/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.1/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

33.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.